CStone Pharmaceuticals ( CSPHF) - Key Metrics
CSPHF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.13 | -$0.16 | $0 | $0 |
| 2025Q4 | $0.14 | -$0.11 | -$0.04 | -$0.04 |
| 2025Q2 | $0.02 | -$0.11 | -$0.03 | -$0.03 |
| 2024Q4 | $0.12 | -$0.08 | -$0.12 | -$0.12 |
| 2024Q2 | $0.20 | $0.01 | -$0.15 | -$0.15 |
CSPHF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.31 |
| 2025Q4 | 0% | -14.19 |
| 2025Q2 | 0% | -9.28 |
| 2024Q4 | 0% | -4.92 |
| 2024Q2 | 0% | 16.69 |
CSPHF
Price: $0.76
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.2 billion